Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Atrophy
CorTechs Labs, Inc. Introduces NeuroQuant: the First Medical Device for Quantifying Regional Brain Atrophy in Patients with Neurodegenerative Disorders
October 5th, 2007
CorTechs Labs Inc., a pioneer in the development of advanced analysis methods for neuroimaging data, announced the commercial release of NeuroQuant(TM), a software tool that can deliver fully-automated neurological magnetic resonance image analysis and reporting to the physician's desktop. This novel capability promises to make quantitative MRI analysis a routine part of clinical practice. Many neurological disorders produce regional brain atrophy that can be detected with MRI scanning. CorTechs' NeuroQuant(TM) image analysis system is the first practical solution for accurately quantifying such changes in clinical settings. Neurologists, neuroradiologists, and other...
Source: Health Business Week (2007-10-05)
|
